These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [The value of CA19-9 in diagnosing hepatocellular carcinoma and intrahepatic cholangiocarcinoma]. Chen Y, Wang ZM, Ren ZG, Le F, Zhang BH, Xia JL, Ye SL, Tang ZY. Zhonghua Gan Zang Bing Za Zhi; 2006 Apr; 14(4):299-300. PubMed ID: 16635306 [No Abstract] [Full Text] [Related]
12. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma. Rimola J, Forner A, Reig M, Vilana R, de Lope CR, Ayuso C, Bruix J. Hepatology; 2009 Sep; 50(3):791-8. PubMed ID: 19610049 [Abstract] [Full Text] [Related]
13. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful? Chung JJ, Kim MJ, Kim KW. J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954 [Abstract] [Full Text] [Related]
15. The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma. Patsenker E, Wilkens L, Banz V, Osterreicher CH, Weimann R, Eisele S, Keogh A, Stroka D, Zimmermann A, Stickel F. J Hepatol; 2010 Mar; 52(3):362-9. PubMed ID: 20137822 [Abstract] [Full Text] [Related]
16. MR imaging of the liver using gadolinium chelates. Low RN. Magn Reson Imaging Clin N Am; 2001 Nov; 9(4):717-43, vi. PubMed ID: 11694435 [Abstract] [Full Text] [Related]
18. [Evaluation of immunohistochemical markers for differential diagnosis of hepatocellular carcinoma from intrahepatic cholangiocarcinoma]. Dong H, Cong WL, Zhu ZZ, Wang B, Xian ZH, Yu H. Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):702-5. PubMed ID: 19173916 [Abstract] [Full Text] [Related]
19. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma. Shiran MS, Isa MR, Sherina MS, Rampal L, Hairuszah I, Sabariah AR. Malays J Pathol; 2006 Dec; 28(2):87-92. PubMed ID: 18376797 [Abstract] [Full Text] [Related]
20. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma. Ushiku T, Shinozaki A, Shibahara J, Iwasaki Y, Tateishi Y, Funata N, Fukayama M. Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341 [Abstract] [Full Text] [Related] Page: [Next] [New Search]